The latest market report published by Acute Market Reports, Inc. “Collagen Meniscus Implant Market: Growth, Future Prospects, and Competitive Analysis, 2019 – 2027” the collagen meniscus implant market was valued at US$ 308.6 Mn in 2018, expected to grow at a CAGR of 5.3% during the forecast period from 2019 to 2027.
The global collagen meniscus implants market is increasing proficiently from 2019 to 2027 accredited to increase in hospital admissions for sports-related knee injury, osteoarthritis, joint overloading, accidents or trauma cases and others along with the growing number of menisectomy procedures. Upgraded bioabsorbable technology in meniscus implants will enhance the demand, e.g. CMI® implant type I, CMI®XL – the next generation and others. Increasing acquisition strategies, new technology expansion, and product launch will further drive the market growth globally.
Browse Full Report Originally Published by Credence Research at https://www.acutemarketreports.com/report/collagen-meniscus-implant-market
In Nov 2015, Ivy Sports Medicine (now Stryker), declared the first orthopedic implantation of its Collagen Meniscus Implant in the United States. Increasing prevalence of chronic and acute meniscus tears in the geriatric population will enhance market growth. In the U.S., incidences of acute meniscal tears are more than 60 cases per 100,000 individuals. Moreover, population older than 60 years of age, the rate of degenerative meniscal injury is around 55-60%. Every year, around one million surgical procedures related to meniscus resection are performed in the U.S., which will drive the market growth in the North America region. According to recent studies and research, Collagen Meniscus Implant (CMI) for medial meniscal substitution has shown improved clinical outcomes with higher safety.
Top manufacturing companies focused on novel product launch and FDA approval on a global scale, mainly in the U.S. and EU market. The North America market contributed maximum revenue attributed to increasing prevalence of bone related disorders, sports injuries (soccer, volleyball, basketball, and athletics), arthritis, joint instability due to knee injury, a large pool of geriatric population, and domicile of key manufacturers in the U.S. market. Many global manufacturers are focusing on widespread investments to further launch new equipment and tools utilized for meniscus implantation procedures.
Key Market Movements:
the collagen meniscus implant is growing at a CAGR of 5.3% for the period
from 2019 to 2027
• Growth in the manufacturing of biocompatible and bioabsorbable materials with enhanced shelf life will increase the product penetration
• Increased health awareness related to osteoarthritis, sports injuries, fractures, and implantation procedures will drive the market growth. Asia Pacific region will grow at a significant pace owing to developments in healthcare infrastructure, enhanced technology expansion, rise in medical expenditure, and medical tourism.
• New product launch along with U.S FDA approval will drive the market growth globally
• Major players in this vertical are RTI Surgical, Active Implants, Orthonika, Stryker Corporation, Zimmer Biomet, Biofixt and others
You can get the sample copy of this research by Credence Research here: https://www.acutemarketreports.com/sample-request/59957
Report Scope by Segments
By Age Group Segment (2017–2027; US$ Mn)
By End Use Segment (2017–2027; US$ Mn)
- Orthopedic Clinics
- Ambulatory Surgical Centers
By Geography Segment (2017–2027; US$ Mn)
- North America (U.S. and Rest of North America)
- Europe (U.K., Germany, France, and Rest of Europe)
- Asia Pacific (Japan, China, India, and Rest of Asia Pacific)
- Rest of World (Middle East & Africa (MEA), Latin America)
About Acute Market Reports (Original Publisher)
Acute Market Reports is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Name: Chris Paul
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US
Toll-Free (US/CANADA) Ph.: +1-855-455-8662